Following Trejo et al. [223], Kim et al. suggested that an IGF-1 increase in BD patients could be part of a peripheral compensatory system as a response to reduced IGF-1 central expression, possibly as an over-activated glycogen synthase kinase-3 pathway that is not appropriately regulated in BD patients. This evidence concerns the gene IGF1 and Behcet disease.